Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04974216
Title Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Lymphoma Academic Research Organisation
Indications

diffuse large B-cell lymphoma

follicular lymphoma

B-cell lymphoma

Therapies

Lenalidomide + Rituximab + Tafasitamab-cxix

Age Groups: senior
Covered Countries FRA | BEL

Facility Status City State Zip Country Details
Clinique Universitaire Saint LUC Recruiting Brussels Belgium Details
CHU de Liège Recruiting Liège Belgium Details
CHRU Mont Godinne Recruiting Yvoir Belgium Details
CHU de Bordeaux - Hôpital Haut Lévêque Recruiting Bordeaux France Details
Institut Bergonié - Bordeaux Recruiting Bordeaux France Details
CH Saint Vincent de Paul Recruiting Lille France Details
CHRU de LILLE - Claude Huriez Recruiting Lille France Details
Chu de Limoges - Hopital Dupuytren Recruiting Limoges France Details
CHU de Nantes - Hôtel Dieu Recruiting Nantes France Details
Centre Antoine Lacassagne Recruiting Nice France Details
APHP - Hôpital Saint Louis Recruiting Paris France Details
Centre Henri Becquerel Recruiting Rouen France Details
Centre René Huguenin - Institut Curie Recruiting Saint-Cloud France Details
Institut de Cancérologie de la Loire Lucien Neuwirth Recruiting Saint-Priest-en-Jarez 42270 France Details
CHU Brabois Recruiting Vandoeuvre les Nancy France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field